% Expired Patents = 25.0

EPO Patents = 2

Forward Citations = 2

Loading Chart...

12 inventors (with patents filed for the assignee):

John E Edwards, Jr (3 out of 17 patents)

Scott G Filler (3 out of 9 patents)

John P Hennessey, Jr (3 out of 3 patents)

4. Michael R Yeaman (2 out of 24 patents)

5. Ashraf S Ibrahim (2 out of 15 patents)

6. Jack D Sobel (1 out of 1 patent)

7. Rinaldo Zurbriggen (1 out of 10 patents)

8. Flavia De Bernardis (1 out of 4 patents)

9. Antonio Cassone (1 out of 10 patents)

10. Silvia Rasi (1 out of 3 patents)

11. Yue Fu (1 out of 10 patents)

12. Michael Timothy Cooke (1 out of 1 patent)

4 patents: Sort by Forward Citations

1. 10857216 - Methods and kits for use in preventing and treating vulvovaginal candidiasis (2020-12-08),

2. 10653757 - Methods and compositions for vaccinating against (2020-05-19),

3. 10130691 - Compositions and methods for treating fungal and bacterial pathogens (2018-11-20),

4. 9610334 - Truncated secretory aspartyl proteinase 2 (2017-04-04),

Company Overview

Novadigm Therapeutics, Inc. is a biotechnology company focused on developing novel immunotherapies for cancer treatment. With a proprietary platform technology, Novadigm is at the forefront of utilizing the body's immune system to target and eradicate cancer cells. The company is dedicated to advancing innovative therapies that have the potential to transform cancer care and improve patient outcomes.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

4 Patents

#9 in Grand Forks, ND

#60 in North Dakota

#60,641 in US

Grand Forks, ND, United States of America

Novadigm Therapeutics, Inc.

Forward Citations = 2

12 inventors:

John E Edwards, Jr (3 out of 17 patents)

Scott G Filler (3 out of 9 patents)

John P Hennessey, Jr (3 out of 3 patents)

4. Michael R Yeaman (2 out of 24 patents)

5. Ashraf S Ibrahim (2 out of 15 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Novadigm Therapeutics, Inc.. Retrieved from https://idiyas.com/company/novadigm-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]